Michael Atkins, MD, Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center, Scholl Professor and Vice Chair Department of Oncology, Georgetown University Medical Center, Discusses Single Agent TKIs In The 1st Line Setting. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019.
http://obroncology.com